Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Hearing the Light
Optogenetics Provides Bright New Prospects for Hearing Restoration
Blood Protein Linked to Mental Disorders
Consciousness-Aiding Protein Produced by Cells Deep in the Brainstem
Single-Cell Cloning Remains a Challenge
Evolving Technologies Help Make It Easier to Meet Regulatory Requirements
For full access to this article login to GEN Select now.
Membrane Protein Solutions for Antibody Discovery
Generation of Monoclonal Antibodies against Difficult Membrane Protein Targets
- Biologics are the fastest growing class of pharmaceuticals, with hundreds of monoclonal antibodies (mAbs) currently being developed and over thirty mAbs approved for the treatment of conditions ranging from cancer to autoimmune and inflammatory diseases. In the case of membrane protein targets, mAbs can avoid many of the pitfalls ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.